Submit a Manuscript to the Journal
Journal of Asthma and Allergy
For an Article Collection on
Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment
Manuscript deadline
Article collection guest advisor(s)
Dr. Amrita Dosanjh,
Rady Children's Hospital
Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment
The Journal of Asthma and Allergy is pleased to announce a new Article Collection dedicated to the role of targeted personalized biologics in the treatment of asthma.
This Collection, edited by the Editor-In-Chief Dr. Amrita Dosanjh, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.
Asthma is a chronic inflammatory lung condition that results in airway obstruction and difficulty breathing. Left untreated, severe asthma flares can lead to hospitalization and even death. Typical front-line treatments of asthma include corticosteroids (which cause immunosuppression with long-term use) and bronchodilators (such as albuterol inhalers). While biologic therapy is relatively new in asthma treatment, Global Initiative For Asthma (GINA) guidelines include biologics as therapeutic options. There are several biologics currently available and in development for the treatment of asthma.
While the call is open to receive manuscripts across the broad spectrum of asthma-modulating biologics, the Editors are particularly interested in manuscripts relating to the following areas:
- Signaling pathways and cellular targets
- Novel mechanisms of action of new candidate biologics
- Anti IL-4 and IL-13 combination biologics and monoclonal antibodies
- Treatment and dosing strategies based on asthma typing
- Biologic switching and combination therapy
- Long-term efficacy and safety studies
Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission: SRNMA. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros.
Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.
The deadline for submitting manuscripts is 1st of April 2026.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.